Demetrix Funding & Investors
Berkeley, CA
Demetrix manufactures natural medicines using synthesis biology. The company uses genetics and computing enabled deciphering technology to produce drugs. It enables refactoring biotechnology microbial hosts for gene synthesis. The company engineers strain to produce co-evolved and bio-inspired medicines and nutraceuticals. The company was founded in 2015 and is headquartered in Emeryville, California.
demetrixbio.comTotal Amount Raised: $61,000,000
Demetrix Funding Rounds
Series A
$50,000,000
Series A Investors
Horizons VenturesTuatara CapitalBerkeley Catalyst FundSeed
$11,000,000
Seed Investors
Horizons Ventures
Funding info provided by Diffbot.